Synthetic biology: at the crossroads of genetic engineering and human therapeutics—a Keystone Symposia report
Jennifer Cable(New York Academy of Sciences), Tingxi Guo(Massachusetts Institute of Technology), Luis Ángel Fernández(Consejo Superior de Investigaciones Científicas), Zhen Xie(Tsinghua University), Timothy K. Lu(Massachusetts Institute of Technology), Rajkamal Srivastava(Boston Biomedical Research Institute), Tim De Coster(Leiden University Medical Center), Samira Kiani(University of Pittsburgh), M.J. Fero(TeselaGen Biotechnology (United States)), Matthew Wook Chang(National University of Singapore), Roger Geiger(Institute of Oncology Research), José M. Lora(Hospital for Special Surgery), Virginia W. Cornish(Columbia University), Jason P. Lynch(Harvard University), Joshua N. Leonard(Northwestern University), Iowis Zhu(Brigham and Women's Hospital), Breanna DiAndreth(Integrated BioTherapeutics (United States)), Owen J. L. Rackham(University of Southampton), David L. Hava(Massachusetts Institute of Technology), Kole T. Roybal(Gladstone Institutes), Gary K. Lee(Sangamo BioSciences (United States)), Rogelio A. Hernández‐López(University of California, San Francisco), Cammie F. Lesser(Broad Institute), Francisco J. Quintana(Hospital Prof. Dr. Fernando Fonseca), Howard L. Kaufman(Rutgers, The State University of New Jersey)
Cited by 10
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Oncolytic viruses: a new class of immunotherapy drugs
|Nature Reviews Drug Discovery|2015|1.6k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k